Kezar Life Sciences Inc (NAS:KZR)
$ 0.7699 0.0042 (0.55%) Market Cap: 56.05 Mil Enterprise Value: -105.77 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 28/100

Kezar Life Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 01:10PM GMT
Release Date Price: $10.39 (+10.53%)
Ryuk Byun
Morgan Stanley & Co. LLC - Analyst

Thank you very much for coming to the 2022 Morgan Stanley Healthcare Conference. My name is Ryuk Byun. I'm an Executive Director in the Healthcare Investment Banking group.

Before we get started, I have research disclosure that I need to read. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Today, we have the pleasure of hosting Kezar. We have Chris Kirk, who has is kind enough to join us for the fireside chat.

And maybe, Chris, before we get started, maybe you can tell us a little bit about your background and also tell us about the Kezar story and how you get started.

Questions & Answers

Chris Kirk
Kezar Life Sciences, Inc. - President & Chief Scientific Officer, Co-Founder

Yes, sure. First of all, thanks for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot